Rwanda experiences a surprising rise in malaria cases in 2024, prompting a reconsideration of vaccine strategies amid drug resistance and environmental challenges, aiming for elimination by 2030.

New insights reveal how our immune system's rapid response proteins may inadvertently promote aging and inflammation, increasing disease risk. Learn how cellular protein assemblies influence longevity and health.

New European guidelines from the CORE-MD consortium establish robust, transparent frameworks for clinical investigations of high-risk medical devices, enhancing safety, efficacy, and innovation across healthcare systems.

The 'Rumpelstiltskin effect' reveals how receiving a clinical diagnosis can itself produce therapeutic benefits, impacting patient well-being beyond specific medical interventions.

Training hospital staff in person-centered dementia care enhances recovery outcomes, staff confidence, and overall service quality for older patients with dementia.

Researchers at BIDMC have created a promising new TB vaccine using mRNA technology, showing potential to improve prevention and move into clinical trials, transforming TB control efforts.

Propranolol, a popular heart medication, is increasingly used by celebrities to manage anxiety. Discover how it works and the risks involved in off-label use for anxiety relief.

California is moving away from federal COVID vaccine guidance amid growing concerns over trust in the CDC and FDA, emphasizing science-based recommendations tailored to local needs.

Liquid biopsies offer a promising avenue for early cancer detection, but current evidence is insufficient to confirm their effectiveness and safety. Experts call for more rigorous research before widespread adoption.

A groundbreaking study reveals that an experimental antibody, ABTAA, may protect kidney blood vessels and reduce fibrosis in chronic kidney disease, offering new hope for treatment.